Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value:
$538.31M
Total Bought:
$196.04M
Total Sold:
$154.23M
Net Transaction:
+$41.81M
Notable People:
Catalio Capital Gp, Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Avalyn Pharmaceuticals Inc1,675,8301,698,851+23,021$55.17M$48.40M8.99%-$6.77M
Bristol-Myers Squibb Company(BMY)412,961499,716+86,755$23.79M$31.18M5.79%+$7.39M
BridgeBio Pharma, Inc.(BBIO)455,041425,111-29,930$33.89M$27.97M5.20%-$5.92M
Parabilis Medicines Inc824,043824,0430$22.55M$26.61M4.94%+$4.05M
Johnson & Johnson(JNJ)138,94699,496-39,450$35.29M$26.34M4.89%-$8.95M
Ascendis Pharma A/S(ASND)31,759101,445+69,686$8.47M$23.11M4.29%+$14.64M
Arrowhead Pharmaceuticals, Inc.(ARWR)0315,247+315,247$0$20.63M3.83%+$20.63M
Syndax Pharmaceuticals, Inc.(SNDX)1,215,6981,023,510-192,188$26.58M$19.24M3.57%-$7.33M
Definium Therapeutics, Inc.(DFTX)562,672497,964-64,708$26.47M$18.95M3.52%-$7.52M
Celcuity Inc.(CELC)0230,609+230,609$0$18.34M3.41%+$18.34M
Septerna, Inc.(SEPN)536,152454,015-82,137$17.96M$17.77M3.30%-$190.1K
Guardant Health, Inc.(GH)092,579+92,579$0$16.51M3.07%+$16.51M
Protagonist Therapeutics Inc106,799112,418+5,619$13.09M$15.84M2.94%+$2.75M
10x Genomics, Inc.CL A(TXG)0164,029+164,029$0$14.82M2.75%+$14.82M
Amylyx Pharmaceuticals, Inc.(AMLX)0505,882+505,882$0$14.72M2.73%+$14.72M
Mineralys Therapeutics, Inc.(MLYS)648,722583,364-65,358$17.50M$14.66M2.72%-$2.84M
Edwards Lifesciences Corp124,778161,121+36,343$11.29M$13.91M2.58%+$2.62M
Corvus Pharmaceuticals, Inc.(CRVS)1,080,8881,021,499-59,389$16.15M$11.77M2.19%-$4.38M
Veradermics, Incorporated(MANE)45,85695,646+49,790$5.64M$11.60M2.15%+$5.96M
Entera Bio LtdSHS03,921,568+3,921,568$0$11.41M2.12%+$11.41M
Disc Medicine, Inc.(IRON)159,384172,709+13,325$11.66M$11.31M2.10%-$351.8K
Odyssey Therapeutics Inc457,839457,8390$8.57M$10.17M1.89%+$1.61M
4d Molecular Therapeutics In471,254684,753+213,499$6.27M$9.80M1.82%+$3.53M
Ultragenyx Pharmaceutical Inc.(RARE)316,252601,760+285,508$10.56M$9.04M1.68%-$1.52M
BioMarin Pharmaceutical Inc.(BMRN)0144,971+144,971$0$8.70M1.62%+$8.70M
Annexon Inc01,986,806+1,986,806$0$8.40M1.56%+$8.40M
Rhythm Pharmaceuticals, Inc.(RYTM)085,614+85,614$0$8.15M1.51%+$8.15M
Structure Therapeutics IncADS276,550260,109-16,441$14.84M$8.13M1.51%-$6.71M
Nektar Therapeutics(NKTR)0126,817+126,817$0$7.68M1.43%+$7.68M
Immunocore Holdings plcADS(IMCR)148,045211,985+63,940$4.70M$6.42M1.19%+$1.72M
Cogent Biosciences, Inc.(COGT)0167,716+167,716$0$5.37M1.00%+$5.37M
Kailera Therapeutics Inc468,750468,7500$10.33M$5.35M0.99%-$4.97M
Natera, Inc.(NTRA)82,18112,530-69,651$22.31M$5.18M0.96%-$17.13M
Fractyl Health Inc6,168,7498,841,707+2,672,958$4.90M$4.81M0.89%-$87.0K
Kardigan Inc312,500312,5000$7.45M$4.61M0.86%-$2.84M
Eledon Pharmaceuticals Inc1,695,0711,637,114-57,957$6.68M$4.14M0.77%-$2.54M
Heartflow, Inc.(HTFL)583,05574,969-508,086$17.11M$3.73M0.69%-$13.38M
Bridgebio Oncology Therapeut318,407699,532+381,125$2.43M$2.87M0.53%+$441.8K
Korsana Biosciences Inc087,702+87,702$0$2.81M0.52%+$2.81M
Freenome Inc0158,170+158,170$0$2.49M0.46%+$2.49M
Protara Therapeutics Inc520,148512,287-7,861$1.99M$1.56M0.29%-$424.5K
Karyopharm Therapeutics Inc940,855976,191+35,336$9.19M$1.19M0.22%-$8.00M
Hyperfine IncCL A1,320,0411,303,155-16,886$1.78M$1.05M0.20%-$729.1K
Metagenomi Therapeutics Inc528,993528,9930$629.5K$560.7K0.10%-$68.8K
Faeth Therapeutics Inc14,71814,7180$367.9K$437.7K0.08%+$69.8K
Outset Med Inc118,279107,456-10,823$511.0K$322.4K0.06%-$188.6K
Adarx Pharmaceuticals Inc011,357+11,357$0$226.5K0.04%+$226.5K
Ataibeckley Inc196,8580-196,858$1.04M$0—-$1.04M
Axsome Therapeutics, Inc.(AXSM)43,1820-43,182$10.57M$0—-$10.57M
Dianthus Therapeutics, Inc.(DNTH)32,9410-32,941$3.21M$0—-$3.21M
Dyne Therapeutics, Inc.(DYN)244,9290-244,929$5.44M$0—-$5.44M
Gilead Sciences, Inc.(GILD)269,3090-269,309$34.02M$0—-$34.02M
Incyte Corporation(INCY)191,6270-191,627$21.72M$0—-$21.72M
Page 1 of 1